Fresh from the stock split exercise in May 2016, Raffles Medical shares power ahead amid the sluggish stock market condition. On 26 July 2016, the healthcare provider announced another set of solid performance. Financial Performance Revenue for second quarter surged 19.8% to $119 million as compared to last year. However, increased in staff costs led to profits of $16.1 million after tax, a marginal increase of only 0.7% as compared to 2015.  The rate of increase for staff costs was higher than the growth in revenue because more specialist consultants and staff as well as increased staff arising from acquisitions in 2015. Raffles Medical continued to have strong cash position, with net cash increased from $53.8 million as at 31 December 2015 to S$92.8 million as at 30 June 2016. This was attributed mainly to strong operating cash flows generated by the Group from its increased business operations. Net cash from operating activities was $23.8 million in 2Q16. Cash and cash equivalents increased by $13.0 million from $110.6 million as at 31 March 2016 to S$123.6 million as ......